Salute e Benessere

Scientific Research Report Highlights Medit i700 wireless, Medit i700, and Medit…

Dr. Donghwan Kim, one of key opinion leaders of Medit, commented on the performance of Medit scanners: "The Medit i700 wireless and Medit i700 have truly transformed our practice. These scanners provide exceptional speed, reliable support, ease of accessibility, competitive pricing, and overall excellent quality. Additionally, the Medit Link software platform offers a wide range of free apps that enhance productivity and streamline workflows." Dr.Donghwan Kim, one of key opinion…
PR Newswire
06/06/2023

Education Resources, Inc. Releases New Toe Walking Course from Internationally…

Liesa developed this new course to build on Toe-Walking: Evaluation and Treatment of Pediatric Equinus Gait (new title for the course formerly called "Part A," same exact course). This brand-new course, Toe Walking: In-Depth Clinical Applications-ON-DEMAND, offers the opportunity to apply the information learned from Part A, while also expanding on this knowledge to help therapists become more confident in their evaluation and treatment skills for toe walking. Liesa developed this new…
PR Newswire
06/06/2023

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP…

Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner. It strengthened its service offering on Regulatory Affairs, Product Quality and Process Compliance, Pharmacovigilance and Clinical Operations activities. In 2004, the Group launched Pharma Education Center (PEC), a training provider for the Life Sciences sector. In 2005, the two partners were joined by Marco Conti who founded C&P Engineering a consulting entity providing…
PR Newswire
06/06/2023

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery The award winningBioXp® systemand associated BioXp De novo kits and BioXp Select kits enable push-button, automated synthesis of gene fragments, clones, variant libraries and mRNA from input sequence or existing DNA. In May, Telesis Bio also introduced their first automated NGS Library Preparation kit for Plasmid Sequencing on the BioXp platform, further advancing the vision of the...
Nasdaq GlobeNewswire
06/06/2023

Biocomposites adds proprietary NanoBone® technology to its portfolio through the…

KEELE, England, June 6, 2023 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces the acquisition of Artoss GmbH (Artoss), a specialist manufacturer of innovative bone graft substitutes for use in orthopaedics, spine, foot and ankle, and dentistry. KEELE,England,June 6, 2023/PRNewswire/ -- Biocomposites, an international...
PR Newswire
06/06/2023

Octapharma presents new data at ISTH 2023 in an ongoing commitment to improve…

People with inherited bleeding disorders, such as haemophilia A and von Willebrand disease, are at risk of recurrent and prolonged bleeds placing a heavy burden on patients' lives. In addition to the risk of potentially life-threatening bleeds, increased bleeding is associated with long-term consequences that severely impair patients' quality of life. Patients with a deficiency of the prothrombin complex of coagulation factors are also at increased risk of bleeding. Such...
PR Newswire
06/06/2023

Genmab to Participate in a Fireside Chat at the Goldman Sachs 44th Annual Global…

Media Release COPENHAGEN, Denmark; June 6, 2023Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Goldman Sachs 44 thAnnual Global Healthcare Conference in Dana Point, CA, 11:20 AM PDT on June 13, 2023 (2:20 PM EDT / 8:20 PM CEST).A webcast of the fireside chat will be available on Genmab's website at https://ir.genmab.com/events-and-presentations#content. About Genmab Genmab is an...
Nasdaq GlobeNewswire
06/06/2023

AccuStem Sciences, Inc. Announces Collaboration Agreement with University…

LONDON and PHOENIX, Ariz., June06, 2023(GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, today announced the establishment of a joint clinical collaboration agreement with University Hospitals. Per the terms of this agreement, University Hospitals will provide tissue samples with clinical outcomes to AccuStem for research purposes. The scope of the agreement covers a multitude of...
Nasdaq GlobeNewswire
06/06/2023

Idorsia has entered into exclusive negotiations with regard to a prospective…

Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland – June06 , 2023Idorsia Ltd (SIX: IDIA) today announced that it has entered into exclusive negotiations with an undisclosed party regarding its operating businesses in the Asia Pacific (ex-China) region, including selected license rights to products from Idorsia's portfolio in those territories, for a total consideration of up to CHF 400 million.This prospective strategic transaction is subject to completion of...
Nasdaq GlobeNewswire
06/06/2023

Santhera Publishes Agenda for its Annual General Meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 6 , 2023 – Santhera Pharmaceuticals (SIX: SANN) today published the agenda for its Annual General Meeting (AGM) , which will be held on June 27 , 2023 , at 10:00 CESTat Haus der Wirtschaft , Hardstrasse 1, 4133 Pratteln, Switzerland ...
Nasdaq GlobeNewswire
06/06/2023

Roborock Unveils the Home Cleaning Center: Pioneering a New Era of Immaculate…

Efficiency: the newly launched 2023 floor scrubber Roborock A10 Ultra features a robust, dual-brush inward rolling design that can picks up both dry and wet dirt, leaving no gaps due to a dual side edge design. With this advanced scrubber, users can now effortlessly and conveniently tackle their daily floor cleaning tasks, ensuring pristine floors with utmost ease. Efficiency: the newly launched 2023 floor scrubber Roborock A10 Ultra features a robust, dual-brush inward rolling design that…
PR Newswire
06/06/2023

MDxHealth Announces its Extraordinary General Shareholders' Meeting

NEWS RELEASE – REGULATED INFORMATION JUNE5 , 2023, 5:30 pm ET/ 23:30 CESTMDxHealth Announces its ExtraordinaryGeneral Shareholders' MeetingIRVINE, CA, and HERSTAL, BELGIUM– June 5, 2023 –MDxHealthSA (Nasdaq and Euronext Brussels: MDXH) (the " Company " or " mdxhealth "), a commercial-stage precision diagnostics company, today invites the holders of securities issued by the Company to its extraordinary general shareholders'...
Nasdaq GlobeNewswire
05/06/2023

Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred…

The financing was led by Novalis LifeSciences LLC with participation from Northpond Ventures, BroadOak Capital Partners and M-185 Corporation, an affiliate of the Company's Chief Executive Officer and Founder, Todd R. Nelson, PhD.The Company also announced the appointment of Paul Meister, a partner at Novalis LifeSciences LLC, to the Company's board of directors immediately following the closing.Please refer to the Company's Form 8-K to be filed with the Securities and Exchange...
Nasdaq GlobeNewswire
05/06/2023

Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster…

Preclinical data on UCART20x22, Cellectis' first allogeneic dual CAR T-cell product candidate to treat B-NHL, presented at an oral sessionEncouraging data presented on gene editing process using Cellectis TALEN ® technology to develop highly efficient HBB gene correction of sickle cell mutationComprehensive analysis to better design efficient TALE Base Editors (TALE-BE) using Cellectis' TALEN ®technology presented in a posterNEW YORK, June05, 2023(GLOBE...
Nasdaq GlobeNewswire
05/06/2023

Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2…

All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL) , with or without Richter's Transformation (RT) , responded to treatment (Objective Response Rate of 100%) 1 GLPG5201 showed no cytokine release syndrome (CRS) higher than grade 2, or immune effector cell-associated neurotoxicity syndrome (ICANS) 2 A functionally closed, automated manufacturing platform for cell therapies at the point-of-care will be shown...
Nasdaq GlobeNewswire
05/06/2023

Bio Decontamination Market worth $339 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777 Browse in-depth TOC on "Bio Decontamination Market" 115 - Tables 29 - Figures 178 - Pages Bio Decontamination Market Scope: Germanyin European bio decontamination market to witness the highest shares during the forecast period. TheEuropebio decontamination...
PR Newswire
05/06/2023

Oxurion Announces Results of the Extraordinary Shareholders' Meeting of 22 May…

Regulated Information Leuven, Belgium, Boston, MA, US – June 5 , 2023–07 .00 PM CET– Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, held its extraordinary shareholders' meeting on May 22, 2023. The shareholders approved all items on the agenda of the extraordinary shareholders' meeting. All documents pertaining to the...
Nasdaq GlobeNewswire
05/06/2023

Synergy Spine Solutions Completes Enrollment of 1-Level IDE Trial

Josh Butters, Synergy Spine Solutions CEO, said: "We are thrilled to announce that we have fully enrolled our 1-Level Synergy Disc trial. This is an incredible achievement for our team and it has been a very rewarding collaboration with some of the best clinical sites and spine surgeons in the US. We are excited to continue following these patients, further building Synergy's clinical evidence, and advancing our pre-market approval strategy for the Synergy Disc in the U.S." Josh…
PR Newswire
05/06/2023

Safe group announces 2022 results

Safe group announces 2022 results2022 sales up +29% to €5.9mGross marginimprovement of +5%Improvement in operating income recurring +19% Éragny-sur-Oise, Fleurieux-sur-l'Arbresle , May5 th, 2023 at 5:45p .m. CET -Safe (FR001400F1V2 - ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for spinal fractures treated in...
Nasdaq GlobeNewswire
05/06/2023

Mithra - Publication of a transparency notification received from Scorpiaux BV

Publication of a transparency notification received from Scorpiaux BVLiege, Belgium ,05June 2023– 17:45 CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of...
Nasdaq GlobeNewswire
05/06/2023

Press release Biocartis Group NV: Biocartis announces resignation CFO

PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 5 June 2023, 17:40 CEST BIOCARTIS ANNOUNCES RESIGNATION CFOMechelen , Belgium,5June 2023 –Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that Jean-Marc Roelandt, the Company's Chief Financial Officer ('CFO') 1, has decided to resign from Biocartis for personal reasons.Biocartis has initiated a selection...
Nasdaq GlobeNewswire
05/06/2023

Monoclonal Antibodies Clinical Trial Experiences Momentum: DelveInsight…

Key Takeaways from the Monoclonal Antibodies Competitive Landscape Report Key Takeaways from the Monoclonal Antibodies Competitive Landscape Report Request a sample and discover the recent advances in monoclonal antibodies treatment @Monoclonal Antibodies Competitive Landscape Report Monoclonal Antibodies Overview Monoclonal antibody (mAb) allows for a far more accurate understanding of the humoral immune response by dissecting it into specific B-lymphocyte populations...
PR Newswire
05/06/2023

Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic…

Fortune Business Insights continued: "One of the foremost drivers influencing the growth of the global market is the increased prevalence of breast cancer across the world, which is expected to result in a large patient population demanding accurate and efficient treatment options. Breast cancer is one of the most prevalent forms of cancer worldwide and improved diagnostics are further expected to result in a greater number of patients being diagnosed. Furthermore, the increasing demand for…
PR Newswire
05/06/2023

Dragonfly Therapeutics Announces the Presentation of Phase 1 DF1001 TriNKET®…

"I am glad to now share that Dragonfly's DF1001 has completed safety evaluation and reached its Phase 2 dose with 67% of patient paired biopsies showing pharmacodynamic response, and clear signs of clinical benefit in both monotherapy and in combination," said Dr. Safran. "We have not seen toxicity nor hit a Maximum Tolerated Dose, and we are seeing encouraging clinical efficacy signals in a heavily pretreated heterogeneous population of patients with advanced cancer. Single agent…
PR Newswire
05/06/2023
Altri  Comunicati